Cargando…
sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
Current anti-VEGF drugs for patients with diabetic retinopathy suffer from short residence time in the vitreous of the eye. In order to maintain biologically effective doses of drug for inhibiting retinal neovascularization, patients are required to receive regular monthly injections of drug, which...
Autores principales: | Altiok, Eda I., Browne, Shane, Khuc, Emily, Moran, Elizabeth P., Qiu, Fangfang, Zhou, Kelu, Santiago-Ortiz, Jorge L., Ma, Jian-xing, Chan, Matilda F., Healy, Kevin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892585/ https://www.ncbi.nlm.nih.gov/pubmed/27257918 http://dx.doi.org/10.1371/journal.pone.0155990 |
Ejemplares similares
-
sFLT1, PlGF, the sFLT1/PlGF Ratio and Their Association with Pre-Eclampsia in Twin Pregnancies—A Review of the Literature
por: Sapantzoglou, Ioakeim, et al.
Publicado: (2023) -
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
por: Herraiz, Ignacio, et al.
Publicado: (2015) -
RNAi Modulation of Placental sFLT1 for the Treatment of Preeclampsia.
por: Turanov, Anton A., et al.
Publicado: (2018) -
sFlt-1 in Chronic Kidney Disease: Friend or Foe?
por: Matsui, Masaru, et al.
Publicado: (2022) -
VEGF and sFLT-1 in serum of PIH patients and effects on the foetus
por: Tang, Yanhong, et al.
Publicado: (2019)